Screener
Ultragenyx Pharmaceutical RARE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $3.29B.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's market capitalization?
- Ultragenyx Pharmaceutical (RARE) reported market capitalization of $3.29B in Q2 2026.
- How has Ultragenyx Pharmaceutical's market capitalization changed year-over-year?
- Ultragenyx Pharmaceutical's market capitalization decreased by 6.4% year-over-year, from $3.51B to $3.29B.
- What is the long-term trend for Ultragenyx Pharmaceutical's market capitalization?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's market capitalization has grown at a -25.1% compound annual growth rate (CAGR), from $9.44B to $2.22B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Ultragenyx Pharmaceutical's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude